CliffBio
small molecule

VARITHENA

POLIDOCANOL

Loss of exclusivity—loss of exclusivity
CompanyBOSTON SCIENTIFIC CORP

Drug detail

Brand nameVARITHENA
Active ingredientPOLIDOCANOL
Strength77.5MG/7.75ML (10MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalDecember 2017
Marketing statusDISCN

More from BOSTON SCIENTIFIC CORP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

VARITHENA patent cliff — loss of exclusivity — | CliffBio